The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.
Yudkin
J S
JS
Department of Medicine, University College London Medical School, England, United Kingdom.
D000419:Albuminuria; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000503:physiopathology; D006801:Humans; D007333:Insulin Resistance; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors